ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

8,778Medicare Part D Prescriptions Filled, Including Refills

Rank: 49 out of 298

$462K Total Retail Price of All Prescriptions

Rank: 40 out of 298

406 Patients Receiving at Least One Drug in Part D
82%Patients 65 Years and Older
35% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in South Dakota
Lower avg

Schedule Two
Controlled Substances

12% of this provider’s 406 patients filled at least one prescription for a schedule two drug, compared to an average of 4%.

Schedule Three
Controlled Substances

12% of this provider’s 406 patients filled at least one prescription for a schedule three drug, compared to an average of 10%.

Risky Drugs to Seniors

1% of this provider’s 6,884 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

21% of this provider’s prescriptions were for brand-name drugs, compared to an average of 22%.

Prescription Price

$53 was the average price of a prescription from this provider, compared to $50 among peers.

Prescriptions per Patient

22 is the average number of prescriptions (including refills) per patient, compared to an average of 20.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in South Dakota
LEVOTHYROXINE SODIUM 382 313 1 1
LISINOPRIL 371 338 2 4
SIMVASTATIN 351 323 3 2
OMEPRAZOLE 299 242 4 3
HYDROCODONE-ACETAMINOPHEN 258 169 S3 5 8
LISINOPRIL-HYDROCHLOROTHIAZIDE 257 246 6 30
METFORMIN HCL 210 175 7 10
METOPROLOL TARTRATE 208 189 8 9
HYDROCHLOROTHIAZIDE 186 181 9 13
ZOLPIDEM TARTRATE 180 135 10 25
LOSARTAN-HYDROCHLOROTHIAZIDE 162 130 11 44
AMLODIPINE BESYLATE 146 137 12 6
TRAMADOL HCL 142 126 13 15
WARFARIN SODIUM 137 113 14 7
FLUOXETINE HCL 134 101 15 50
ATORVASTATIN CALCIUM 103 101 16 14
METOPROLOL SUCCINATE 103 78 16 12
GABAPENTIN 100 47 18 20
ATENOLOL 90 87 19 16
ALLOPURINOL 81 81 20 28
TAMSULOSIN HCL 81 80 20 24
CYMBALTA 80 41 22 67
FENTANYL 79 55 S2 23 32
FUROSEMIDE 76 65 24 5
MORPHINE SULFATE ER 72 22 S2 25 122
CARBIDOPA-LEVODOPA 71 55 26 49
CELEBREX 67 55 27 86
OXYCODONE HCL-ACETAMINOPHEN 67 28 S2 27 185
PROPRANOLOL HCL 64 64 29 85
CLOPIDOGREL 63 62 30 36
DONEPEZIL HCL 60 60 31 22
GLIPIZIDE 55 41 32 69
MIRTAZAPINE 54 42 33 37
PREDNISONE 54 38 33 33
NEXIUM 54 29 33 40
ALENDRONATE SODIUM 50 41 36 21
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on May 9, 2008.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.